Loading patent…
AssigneeRuse Technologies, LLC
InventorsRAYMOND E. IDEKER, RICHARD B. RUSE, SCOTT BOHANAN
Estimating the term…
Cardiac defibrillation or cardioversion waveform energy control systems employ transvenous ICDs or subcutaneous SICDs for treating cardiac arrhythmias. The systems comprise differentially driven amplifier circuit operational modes to control the delivery of defibrillation or cardioversion electrical shocks, wherein the shock waveforms are constant current, constant voltage, or constant energy. Biphasic arbitrary shock waveforms deliver increasing and or level energy with increasing time as represented by phase 1 ascending ramp, ascending exponential, ascending chopped, ascending stepped, ascending curved, square, rectilinear or level and or any combination of geometric shaped ascending or level waveforms.
A cardiac defibrillation or cardioversion waveform energy control system for treating cardiac arrhythmias in a patient, which comprises differentially driven amplifier circuit operational modes to control the delivery of defibrillation or cardioversion electrical shocks, wherein the shock waveforms are constant current, constant voltage, or constant energy.
A system for a dynamic amplifier-based transvenous ICD or SICD system that is controlled via software commands and is capable of delivering all known BTE shock waveforms with any tilt angle specified via software in addition to thousands of protocols using ascending waveforms which offer constant energy, constant voltage or constant current modes of operation which are unique and novel to the field.
An amplifier-based transvenous ICD or SICD system whereby any ascending arbitrary waveform within the limits of the stored energy within a transvenous ICD or SICD may be delivered using software commands, enabling this system to maximize the reduction in damage to the heart and have the highest statistical cardioversion and defibrillation rate.
Dependencies are inferred from the claim text.